MedPath

Cholecalciferol and Calcifediol Are Both Useful to Improve Vitamin D Serum Levels

Not Applicable
Recruiting
Conditions
Hypovitaminosis D
Interventions
Dietary Supplement: Vitamin D
Registration Number
NCT06138249
Lead Sponsor
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Brief Summary

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment

Detailed Description

Patients with hypovitaminosis D are randomized into three arms of treatment:

Group A: Calcifediol 0,266mg each month Group B: Cholecalciferol 25000UI each 15 days Group C: Calcifediol 4 drops per day. Serum levels of vitamin D are dosed after one month of treatment to support the best dosage of Vitamin D intake.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
90
Inclusion Criteria
  • Hypovitaminosis D (<20ng/mL)
Exclusion Criteria
  • Osteoporosis (T score <-2.5SD)
  • Renal or hepatic diseases

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Calcifediol each monthVitamin DCalcifediol 0,266 mg each month
Cholecalciferol 25.000 UIVitamin DCholecalciferol 25000UI each 15 days
Calcifediol 4 drops each dayVitamin DCalcifediol 4 drops each day
Primary Outcome Measures
NameTimeMethod
level of Vitamin DBetween recruitment and 6 month

Blood dosage of vitamin D

Secondary Outcome Measures
NameTimeMethod
DEXABetween recruitment and 18 months

DEXA is a radiographic measurement of Bone Mass

Trial Locations

Locations (1)

University of Bari

🇮🇹

Bari, Italy

© Copyright 2025. All Rights Reserved by MedPath